Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | BCL9 | O00512 | 1/20 | 0.42 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29941922 | 0.90 | TDP1 (0.58) | TDP1ATML3MBTL1KDM4EMEN1 | |
| SCHEMBL644115 | 0.90 | TDP1 (0.58) | TDP1ATML3MBTL1KDM4EMEN1 | |
| SCHEMBL499472 | 0.89 | KMT2A (0.67) | TDP1ATML3MBTL1LMNAKDM4E | |
| SCHEMBL9312497 | 0.88 | KMT2A (0.59) | L3MBTL1LMNAKDM4EMEN1RECQL | |
| SCHEMBL8934268 | 0.88 | KDM4E (0.60) | TDP1ATML3MBTL1KDM4EMEN1 | |
| SCHEMBL9468274 | 0.87 | TDP1 (0.55) | TDP1ATML3MBTL1KDM4EMEN1 | |
| SCHEMBL28398105 | 0.86 | TDP1 (0.46) | TDP1ATML3MBTL1LMNAKDM4E | |
| SCHEMBL9181885 | 0.86 | KDM4E (0.59) | TDP1ATML3MBTL1LMNAKDM4E | |
| SCHEMBL28371332 | 0.86 | KDM4E (0.59) | TDP1ATML3MBTL1LMNAKDM4E | |
| SCHEMBL11591925 | 0.86 | KDM4E (0.59) | TDP1ATML3MBTL1LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0434437-A2 | Photohardenable or thermohardenable compositions and photosensitive materials utilising such photohardenable compositions | THE MEAD CORPORATION (US) | 1991-06-26 | — | — | EP | claimed |
| EP-3357943-B1 | MODIFIED CONJUGATED DIENE-BASED POLYMER AND METHOD OF PREPARING THE SAME | LG CHEMICAL LTD (KR) | 2022-07-20 | — | — | EP | disclosed |
| CN-113308705-A | Electrooxidation preparation method of kresoxim-methyl and trifloxystrobin intermediate | 湖南大学 | 2021-08-27 | — | — | CN | disclosed |
| CN-111620781-B | Alpha-alkyl phenylacetic acid compound with high optical activity and preparation method and application thereof | 南京工业大学 | 2021-05-25 | — | — | CN | disclosed |
| US-10906995-B2 | Modifier and modified and conjugated diene-based polymer prepared using the same | LG CHEM, LTD. | 2021-02-02 | — | — | US | disclosed |
| CN-111620781-A | Alpha-alkyl phenylacetic acid compound with high optical activity and preparation method and application thereof | 南京工业大学 | 2020-09-04 | — | — | CN | disclosed |
| US-10450387-B2 | Modifier, modified and conjugated diene-based polymer and methods for preparing them | LG CHEM, LTD. (KR) | 2019-10-22 | — | — | US | disclosed |
| EP-3312199-B1 | AZASILANE-BASED MODIFIER, AND METHOD FOR PREPARING MODIFIED AND CONJUGATED DIENE-BASED POLYMER USING THE SAME | LG CHEMICAL LTD (KR) | 2019-07-03 | — | — | EP | disclosed |
| US-20190002598-A1 | AZASILANE-BASED MODIFIER, AND METHOD FOR PREPARING MODIFIED AND CONJUGATED DIENE-BASED POLYMER USING THE SAME | LG CHEM, LTD. (KR) | 2019-01-03 | — | — | US | disclosed |
| US-20180371113-A1 | MODIFIER, MODIFIED AND CONJUGATED DIENE-BASED POLYMER AND METHODS FOR PREPARING THEM | LG CHEM, LTD. (KR) | 2018-12-27 | — | — | US | disclosed |
| EP-1841869-A4 | USE OF ATBG1 GENE FOR THE GENERATION OF TRANSGENIC PLANTS WITH INCREASED RESISTANCE TO VARIOUS ABIOTIC STRESS | POSTECH FOUNDATION (KR) | 2009-01-28 | — | — | EP | disclosed |
| EP-1841869-A1 | USE OF ATBG1 GENE FOR THE GENERATION OF TRANSGENIC PLANTS WITH INCREASED RESISTANCE TO VARIOUS ABIOTIC STRESS | Postech Foundation (KR) | 2007-10-10 | — | — | EP | disclosed |
| WO-2006068442-A1 | USE OF ATBG1 GENE FOR THE GENERATION OF TRANSGENIC PLANTS WITH INCREASED RESISTANCE TO VARIOUS ABIOTIC STRESS | POSTECH FOUNDATION (KR) | 2006-06-29 | — | — | WO | disclosed |
| US-6600080-B1 | Method of alcohols such as cyclohexanedimethanol, a benzyl ester is obtained, for example, by the reaction between a benzyl compound and carboxylic acid in the presence of oxygen and a catalyst including palladium, gold ultra fine particles | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-07-29 | — | — | US | disclosed |
| EP-1090902-A2 | Method for producing alcohols such as cyclohexanedimethanol | Nippon Shokubai Co., Ltd. (JP) | 2001-04-11 | — | — | EP | disclosed |
| US-5658924-A | CIRCULATORY, RESPIRATORY, NERVOUS SYSTEM DISORDERS | THE GREEN CROSS CORPORATION (JP) | 1997-08-19 | — | — | US | disclosed |
| EP-0728128-A1 | SUBSTITUTED PHENYL COMPOUNDS | RHONE-POULENC RORER LIMITED (GB) | 1996-08-28 | — | — | EP | disclosed |
| EP-0670320-A1 | 1,8-NAPHTHYRIDIN-2-ONE DERIVATIVE AND USE THEREOF- | THE GREEN CROSS CORPORATION (JP) | 1995-09-06 | — | — | EP | disclosed |
| WO-1995013262-A1 | SUBSTITUTED PHENYL COMPOUNDS | RHONE-POULENC RORER LIMITED (GB) | 1995-05-18 | — | — | WO | disclosed |
| EP-0434437-A2 | Photohardenable or thermohardenable compositions and photosensitive materials utilising such photohardenable compositions | THE MEAD CORPORATION (US) | 1991-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190002598-A1 | AZASILANE-BASED MODIFIER, AND METHOD FOR PREPARING MODIFIED AND CONJUGATED DIENE-BASED POLYMER USING THE SAME | RIF1, RAE1, TRRAP | TDP1 1209/4885ATM 2956/4885L3MBTL1 4730/4885 |
| US-10450387-B2 | Modifier, modified and conjugated diene-based polymer and methods for preparing them | UFM1, F13A1, ITGAM | TDP1 2436/4885ATM 3156/4885L3MBTL1 3716/4885 |
| US-10906995-B2 | Modifier and modified and conjugated diene-based polymer prepared using the same | RIF1, FDFT1, CAD | TDP1 1937/4885ATM 3097/4885L3MBTL1 4294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.